-- Merger and acquisition activities will increase as economy improves
LONDON, June 5, 2013 /PRNewswire/ -- Government funding, growth and consolidation of the middle class, and the rise in non-communicable diseases will enable Turkey to remain one of the sought-after countries for healthcare investment. Turkey offers immense potential for companies across the healthcare spectrum, from healthcare technology device suppliers to pharmaceutical and clinical diagnostic firms.
New analysis from Frost & Sullivan (http://www.connectedhealth.frost.com), Healthcare Landscape and Outlook in Turkey, finds that the market earned revenues of more than $23.29 billion in 2012 and estimates this to reach $29.62 billion in 2015.
The stability of the political environment and focus on hospital modernisation, funding and private sector expansion have aided the growth of the healthcare market in Turkey.
"The government has encouraged market development through public-private partnerships, establishing health facilities, research and development units, technology centres, and institutes of medical sciences in 29 cities," says Frost & Sullivan Healthcare Research Analyst Hilal Cura. "Moreover, the government aims to standardise licensing criteria and accreditation systems by 2014 to improve healthcare accessibility and quality."
Government incentives also support advancements in biotechnology-based drugs, which are fast becoming more popular than chemical drugs. Mobile health and homecare services will be another key area for growth. In fact, five million devices in the country, from patient monitors to doctors' smart phones, will be connected through machine-to-machine systems by 2015.
The emergence of Turkey as a preferred medical travel destination due to quality medical facilities, the availability of specialists, capabilities in complex surgical procedures, cost competitiveness, and shorter waiting times for patients than most European countries, further spur revenues.
The emphasis on specialisation will provide added opportunities for healthcare providers. Several institutions such as Acibadem, Florence Nightingale, Memorial and Dunya Goz Groups have already allocated resources to specialise in oncology, cardiovascular diseases and ophthalmology.
"Merger and acquisition activities will abound in the country due to the rapid growth of the economy and increasing innovation in local pharmaceutical, medical device and healthcare service enterprises," remarks Cura.
If you are interested in more information on this research, please send an e-mail to Anna Zanchi, Corporate Communications, at email@example.com
Healthcare Landscape and Outlook in Turkey is part of the Connected Health Growth Partnership Service program. Frost & Sullivan's related research services include: Asia Pacific Healthcare Outlook, Healthcare Opportunities in India, Healthcare Opportunities in Brazil, and Healthcare Opportunities in Mexico. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
SOURCE Frost & Sullivan